BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
MYC
,
T cell differentiation
,
Arthritis
,
Intestine
,
Autoimmunity
,
Fluoxetine
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptor PD1
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Melanoma tumor biopsies from patients treated with anti-PD1 therapy
Melanoma biopsies of patients pre anti-PD-1 therapy with Pembrolizumab
Tumor biopsy at C1D1 or C2D8 of ovarian cancer patients treated with guadecitabine + pembrolizumab
CD4+ T follicular helper (Tfh) cells S1PR2+, from chicken gamma globulin (CGG) immunized mice
Relapsed follicular lymphomas before and after pidilizumab therapy
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 rece…
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory…
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpo…
Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in pri…
Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1…
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a…
Efficacy and Safety Evaluation of PD1-BCMA-CART
PD1 and PARP for Maintenance Therapy in NSLLC
Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Meta…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ